These final results, along with a earlier report exhibiting that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 support the principle of targeting ACKR3 as a novel strategy to modulate the opioid system, which could open new therapeutic avenues for opioid-associated Issues. These success recommend that conolidine https://cullenr050elj9.wikiexpression.com/user